E Merck KG's board of partners has announced the appointment of new CEOs to Merck KGaA’s executive board in a pivotal step in the company's ongoing growth strategy. Jean-Charles Wirth will ...

Summary: The Board erred by failing to explain why it discarded material and unrebutted evidence that a reference constitutes prior art.

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

Merck has been raising its R&D budget by a healthy ... Perlmutter is taking an independent seat on the board at South San Francisco-based Insitro, a specialist in applying artificial intelligence ...

The general mood among these heavyweight investors is divided, with 63% leaning bullish and 36% bearish. Among these notable ...

Merck said on Tuesday it has opened a $1-billion facility at its North Carolina site, the latest drugmaker to boost its U.S.

Recursion Pharmaceuticals appointed former FDA principal deputy commissioner Namandjé Bumpus, PhD, and Elaine Sun, the COO and CFO of Mammoth Biosciences, to its board of directors. CAMP4 Therapeutics ...

Yesterday, the U.S. Court of Appeals for the Federal Circuit issued a precedential decision vacating the Patent Trial and Appeal Board’s determination that CQV failed to show the unpatentability of ...

At its sprawling complex in Durham, N.C., Merck has opened a new $1 billion, 225,000-square-foot manufacturing plant slated to produce bulk substance for its megablockbuster HPV vaccine Gardasil.

As Merck & Co. hunts for an ideal spot to set up a new commercial facility, Delaware is looking to bolster its odds with a cash sweetener. Monday, Delaware’s state investment board approved a $ ...